Literature DB >> 5429181

Penetration of clindamycin into synovial fluid.

M A Plott, H Roth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5429181     DOI： 10.1002/cpt1970114577

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  8 in total

1.  Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.

Authors:  Emmanuel Curis; Vincent Pestre; Vincent Jullien; Luc Eyrolle; Denis Archambeau; Philippe Morand; Laure Gatin; Matthieu Karoubi; Nicolas Pinar; Valérie Dumaine; Jean-Claude Nguyen Van; Antoine Babinet; Philippe Anract; Dominique Salmon
Journal:  Infection       Date:  2015-04-03       Impact factor: 3.553

2.  Clindamycin bioavailability from clindamycin-2-palmitate and clindamycin-2-hexadecylcarbonate in man.

Authors:  A A Forist; R M DeHaan; C M Metzler
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

3.  Effect of protein concentration and binding on antibiotic assays.

Authors:  L R Peterson; E A Schierl; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

4.  Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis.

Authors:  Naïm Bouazza; Vincent Pestre; Vincent Jullien; Emmanuel Curis; Saïk Urien; Dominique Salmon; Jean-Marc Tréluyer
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

5.  Simple assay for clindamycin in the presence of aminoglycosides.

Authors:  F R Ervin; W E Bullock
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.

Authors:  Valérie Zeller; Arnaud Dzeing-Ella; Marie-Dominique Kitzis; Jean-Marc Ziza; Patrick Mamoudy; Nicole Desplaces
Journal:  Antimicrob Agents Chemother       Date:  2009-10-19       Impact factor: 5.191

7.  Concentrations of some antibiotics in synovial fluid after oral administration, with special reference to antistaphylococcal activity.

Authors:  M A Sattar; S P Barrett; M I Cawley
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

8.  Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study.

Authors:  Borg Leijtens; Joris B W Elbers; Patrick D Sturm; Bart Jan Kullberg; Berend W Schreurs
Journal:  BMC Infect Dis       Date:  2017-05-02       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.